What Pharma Medico does

Pharma Medico Ltd is a privately-held UK limited company headquartered in Longton, Staffordshire, that operates the Nourkrin® brand of hair growth supplements. The company sells two core products — Nourkrin® Woman and Nourkrin® Man — built around a proprietary bioactive proteoglycan ingredient (Marilex® and Marilex®-M respectively), a fractionated fish extract containing specific lectican proteoglycans that the company positions as a Proteoglycan Replacement Therapy addressing Proteoglycan Follicular Atrophy. The technology is protected by intellectual property rights held for over 30 years and is supported by more than 100 peer-reviewed clinical studies and papers.

The business model is direct-to-consumer e-commerce anchored at nourkrin.co.uk, supplemented by recommendations through a network of healthcare professionals (doctors, dermatologists, trichologists) and a partnership with the World Hair Council. Pricing is publicly disclosed at approximately £50.95 per 60-tablet one-month pack and £127.95 per 180-tablet three-month pack, with a 20% first-order discount offered in exchange for newsletter signup. The company accepts major credit cards and ships primarily within the UK, with claimed distribution into the United States and Brazil supported by FDA, ANVISA, and COFEPRIS regulatory acceptances.

No revenue, headcount, funding, leadership, or M&A activity is disclosed in the source material. The company is a small, mature consumer health business with a long-established but narrow product line, an owned digital storefront as primary channel, and a clinical-evidence-driven marketing approach. Strategic activity appears limited to ongoing brand maintenance, ingredient IP stewardship, and the World Hair Council partnership.

Name

Pharma Medico

Legal name

Pharma Medico Ltd

Website

https://nourkrin.co.uk

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Pharma Medico Ltd is a UK private company that sells Nourkrin® Woman and Nourkrin® Man hair growth supplements directly to consumers via nourkrin.co.uk, using a proprietary Marilex® proteoglycan ingredient, and reaching hundreds of thousands of users globally over 30+ years.

Ownership category

akta.pro rank

Product category

Hair Growth Supplements

NAICS

Food (Health) Supplement Retailers (456191), Medicinal and Botanical Manufacturing (325411), Health and Personal Care Retailers (456)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Treatments & Scalp Care (Serums, Oils, Anti-dandruff, Growth) (CRABABAE)

akta.pro secondary industries

Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

Keywords

• Hair growth supplements
• Proteoglycan replacement therapy
• Bioactive hair formulas
• Natural hair loss treatment
• Clinical hair restoration

Headquarters

HQ city

Longton, Staffordshire

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Marketing or Sales, Supply Chain, Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Product Sales - Nourkrin® Woman: Direct-to-consumer sales of Nourkrin® Woman supplements - a bioactive proteoglycan formula tablet product sold in 60-tablet (1 month) and 180-tablet (3 month) packaging. Sold through e-commerce platform and recommended by healthcare professionals.
2. Product Sales - Nourkrin® Man: Direct-to-consumer sales of Nourkrin® Man supplements - a bioactive proteoglycan formula tablet product specifically formulated for men. Sold in 60-tablet (1 month supply at £50.95) and 180-tablet (3 month supply at £127.95) packaging.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Pharma Medico manufactures and sells the Nourkrin® line of bioactive proteoglycan formula supplements — Nourkrin Woman and Nourkrin Man — formulated with the proprietary Marilex®/Marilex®-M fish-derived proteoglycan ingredients, packaged as 60-tablet (1-month) and 180-tablet (3-month) supplies. Products are sold direct-to-consumer through the official nourkrin.co.uk webshop and distributed via healthcare professional referrals (doctors, dermatologists, trichologists, pharmacists), targeting hair growth disorders including Male/Female Pattern Hair Loss, Telogen Effluvium, and Postpartum Hair Loss.

Product overview

Pharma Medico's Nourkrin product line consists of two core bioactive proteoglycan-based hair growth supplements: Nourkrin Woman for healthy hair growth in women and Nourkrin Man for hair growth and preservation in men. Both products utilize the proprietary Marilex/Marilex-M ingredient, a naturally derived fish extract rich in specific papillary proteoglycans, delivered as a Proteoglycan Replacement Therapy to normalize the Hair Growth Cycle and address hair loss conditions such as Proteoglycan Follicular Atrophy.

Differentiator

Problem solved

Functional benefit

Brands

• Nourkrin® Woman: Bioactive proteoglycan formula supplement specifically formulated for women to help maintain a normal healthy Hair Growth Cycle and support normal healthy hair growth.
• Nourkrin® Man
• Marilex®
• Marilex®-M

Products and services

• Nourkrin Woman A safe and drug-free bioactive proteoglycan formula tablet supplement specifically formulated for women to help maintain a normal healthy Hair Growth Cycle and support normal healthy hair growth. Contains the proprietary Marilex ingredient (fractionated fish extract rich in specific papillary proteoglycans). Sold in 60-tablet (1-month) and 180-tablet (3-month) packs at £50.95 and £127.95 respectively. Target conditions: Female Pattern Hair Loss, Postpartum Hair Loss, Telogen Effluvium, Menopause-related thinning, and stress-induced hair loss.
• Nourkrin Man A safe and drug-free bioactive proteoglycan formula tablet supplement specifically formulated for men to help approach hair loss and thinning effectively and support a normal healthy Hair Growth Cycle. Contains the proprietary Marilex-M ingredient with extra proportions of decorin and versican proteoglycans essential for addressing follicle shrinkage during Male Pattern Hair Loss. Sold in 60-tablet (1-month, £50.95) and 180-tablet (3-month, £127.95) packs at 2 tablets daily. Clinically documented outcomes: 75% of men experienced regrowth with +35.7% hair density.

Quantifiable outcome

• 75% of men experienced regrowth of hair with +35.7% in hair density in clinical trials
• +5 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• World Hair Council (WHC)coreStrategic or Co-development PartnerNourkrin® supports the World Hair Council (WHC) and its global network of leading hair growth experts dedicated to bringing a better quality of life and reliable information to hair loss sufferers. The WHC verifies Nourkrin® testimonials and provides credibility to the brand.

Scale indicators8 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• HairMax (Lexington International): HairMax manufactures FDA-cleared laser therapy devices for hair growth. Comparable to Nourkrin® in targeting the drug-free/natural hair loss treatment segment, though via a different mechanism (LLLT devices vs. proteoglycan supplementation).
• Keeps: Keeps is a subscription-based DTC telehealth company focused specifically on male pattern hair loss, offering finasteride and minoxidil. Comparable to Nourkrin® Man in targeting the male hair loss segment with subscription DTC, but offering FDA-approved pharmaceuticals rather than supplements.

Regional players

• Olaplex: Olaplex is a leading professional haircare brand focused on hair repair, strength, and damage prevention rather than regrowth. Comparable to Nourkrin® as a science-driven haircare brand with strong professional endorsement, but addresses hair damage rather than hair loss treatment.

Broad incumbents

• Bosley: Bosley is a long-established hair restoration company offering surgical transplants and non-surgical treatments. Comparable to Nourkrin® as a hair loss solutions provider, but operates in the higher-touch clinical/procedural end of the market rather than oral supplements.
• Rogaine (Johnson & Johnson): Rogaine is the market-leading FDA-approved minoxidil brand for hair loss treatment. While Nourkrin® is an oral supplement and Rogaine is a topical drug, both compete for the same hair loss consumer wallet and Rogaine represents the established clinical incumbent against which Nourkrin® positions its drug-free alternative.
• HRT (Hair Restoration Technique) / Propecia (Merck): Propecia (finasteride) is Merck's FDA-approved prescription drug for male pattern hair loss. Comparable to Nourkrin® Man as a male-pattern hair loss treatment, but operates as a pharmaceutical incumbent with the strongest clinical evidence base — the primary competitive threat to Nourkrin®'s positioning.
• Hims & Hers Health: Hims & Hers is a major telehealth and DTC consumer health company that offers hair loss treatments (primarily minoxidil and finasteride) plus wellness supplements. Comparable as a DTC hair loss solutions provider with subscription model, but operates at much larger scale and broader category scope than Nourkrin®.

Direct peers

• Nutrafol: Nutrafol is a leading clinically-tested hair growth supplement brand targeting men and women with botanical/nutraceutical formulations. Comparable to Nourkrin® in target market (male/female pattern hair loss), DTC distribution model, and subscription pricing, but with stronger U.S. brand awareness and broader ingredient portfolio.
• Viviscal: Viviscal is a hair growth supplement brand using a marine complex called AminoMar® — directly comparable to Nourkrin®'s marine-derived Marilex® approach. Both target the same hair thinning/loss consumer with oral supplements and emphasize clinical evidence, making them the closest head-to-head competitor in the natural hair growth supplement category.
• Vegamour: Vegamour is a plant-based hair wellness brand offering supplements and topical products for hair growth. Directly comparable to Nourkrin® in targeting natural/DTC hair loss consumers, with a similar subscription model and clinical-claims positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharma-medico

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Medico